ACE2 and COVID-19: However, we should take into consideration the protective effect of ACE2 against Ang II-induced deleterious effects because the overactivation of the Angiotensin (Ang) II/AT1R axis may explain the multiorgan dysfunction seen in COVID-19 patients with acute and chronic inflammation [22].